Re-profiling of selected FDA approved drugs against nuclear factor kappa beta (nf-kb) pathway in ischemic stroke
Awais Ali (22217)
Re-profiling of selected FDA approved drugs against nuclear factor kappa beta (nf-kb) pathway in ischemic stroke - Islamabad (unpublished) 2019 - ix, 55 p. : ill., Col. ; 30 cm. +CD
A thesis submitted in partial fulfillment of the requirement for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences. Includes bibliographical references Thesis supervisor: Dr. Fawad Ali Shah
Thesis (M.Phil.)--Riphah International University, 2019
English
Pharmacology--Bioinformatics resources--Morphology analysis--Neurobehavioral testing--Drug treatment--RIPS
615.1 / AWA
Re-profiling of selected FDA approved drugs against nuclear factor kappa beta (nf-kb) pathway in ischemic stroke - Islamabad (unpublished) 2019 - ix, 55 p. : ill., Col. ; 30 cm. +CD
A thesis submitted in partial fulfillment of the requirement for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences. Includes bibliographical references Thesis supervisor: Dr. Fawad Ali Shah
Thesis (M.Phil.)--Riphah International University, 2019
English
Pharmacology--Bioinformatics resources--Morphology analysis--Neurobehavioral testing--Drug treatment--RIPS
615.1 / AWA